Scarica l'app Stockscreener
0.6298
0.98%
0.0061
Dopo l'orario di chiusura:
.60
-0.0298
-4.73%
Precedente Chiudi:
$0.6237
Aprire:
$0.6
Volume 24 ore:
424.41K
Relative Volume:
0.64
Capitalizzazione di mercato:
$5.71M
Reddito:
$895.50K
Utile/perdita netta:
$-26.30M
Rapporto P/E:
-0.0096
EPS:
-65.5728
Flusso di cassa netto:
$-23.84M
1 W Prestazione:
-16.14%
1M Prestazione:
-45.71%
6M Prestazione:
-65.01%
1 anno Prestazione:
-87.93%
Intervallo 1D:
$0.5601
$0.63
Intervallo di 1 settimana:
$0.5601
$0.838
Portata 52W:
$0.5601
$6.29
Mainz Biomed N V Stock (MYNZ) Company Profile
Nome
Mainz Biomed N V
Settore
Industria
Telefono
-
Indirizzo
-
Compare MYNZ vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
0.6298 | 5.65M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
515.12 | 192.95B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
211.25 | 147.43B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
630.73 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.34 | 35.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
328.66 | 32.13B | 3.17B | 642.63M | 539.81M | 10.77 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-14 | Iniziato | Maxim Group | Buy |
| 2024-11-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | Iniziato | H.C. Wainwright | Buy |
Mainz Biomed N V Borsa (MYNZ) Ultime notizie
Mainz Biomed secures $6 million funding, shifts focus to pancreatic cancer - Investing.com India
Mainz Biomed Announces $6 Mln Private Placement In Two Tranches To Fund Operations, Stock Down - Nasdaq
Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update - TradingView
Mainz Biomed Secures Strategic Investment and Restructures Operations - TipRanks
Mainz Biomed Raises Up to $6 Million in Two-Step Preferred Stock Investment From David Lazar - TradingView
Mainz Biomed N.V. announced that it expects to receive $6 million in funding - marketscreener.com
How does Mainz Biomed N.V. compare to its peersJuly 2025 Analyst Calls & Real-Time Volume Analysis Alerts - mfd.ru
How supply chain issues affect Mainz Biomed N.V. stockJuly 2025 Macro Moves & Community Consensus Trade Alerts - mfd.ru
Mainz Biomed completes ATM share sales, retains capacity - The Globe and Mail
Mainz Biomed raises $2.15 million through at-the-market share offering - Investing.com Canada
Can IDT Corporation benefit from deglobalizationWeekly Profit Summary & Community Trade Idea Sharing - baoquankhu1.vn
AI Stocks: Will AdvanSix Inc stock hit new highs in YEARCPI Data & Real-Time Sentiment Analysis - baoquankhu1.vn
What’s the beta of Mainz Biomed N.V. stockWeekly Trend Recap & AI Forecasted Entry/Exit Points - mfd.ru
Mainz Biomed NV Files Initial Statement of Beneficial Ownership for CEO and Director Guido Baechler - Longbridge
Growth Recap: How does Mainz Biomed NV compare to its peers2025 Support & Resistance & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Analyst Calls: Is Maplebear Inc stock a buy or sellJuly 2025 Big Picture & High Return Trade Guides - baoquankhu1.vn
Mainz Biomed N.V. to Present Innovative Cancer Detection Research at AACR 2026 Annual Meeting - Quiver Quantitative
Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting - GlobeNewswire
Income Plays: How does Mainz Biomed NV compare to its peers2025 Sector Review & Risk Managed Investment Strategies - baoquankhu1.vn
CEO Moves: Will Mainz Biomed NV stock continue upward momentum - Bộ Nội Vụ
Trading Action: Why Mainz Biomed NV stock could outperform in 2025 - moha.gov.vn
Is Mainz Biomed N.V. (4TO) stock among top earnings playsWeekly Market Summary & AI Forecasted Stock Moves - Улправда
Is Mainz Biomed N.V. stock a safe buy before earningsMarket Weekly Review & Low Risk High Reward Ideas - Улправда
Earnings Report: Will Mainz Biomed N.V. stock see PE expansionJuly 2025 Big Picture & Entry Point Strategy Guides - ulpravda.ru
Entry Recap: How resilient is Mainz Biomed N.V. stock in market downturns2025 Growth vs Value & Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is Mainz Biomed N.V. (4TO) stock undervalued after correction2025 Technical Patterns & Fast Exit and Entry Strategy Plans - Улправда
How strong is Mainz Biomed N.V. stock revenue growthMarket Sentiment Indicators & Big Gains Small Capital - ulpravda.ru
Is Mainz Biomed N.V. stock a buy for dividend growthStock Screening Results & Minimal Investment Portfolio - Улправда
Retail Trends: Will Mainz Biomed NV stock see PE expansionWeekly Profit Analysis & Safe Capital Growth Tips - moha.gov.vn
Mainz Biomed Provides Review of 2025 Highlights - Chartmill
Mainz BioMed N.V. / NL0015000LC2 - AD HOC NEWS
Earnings Risk: Why analysts upgrade Pony AI Inc Depositary Receipt stock2025 Short Interest & Weekly Consistent Profit Watchlists - moha.gov.vn
Is Mainz Biomed NV a good long term investmentBullish Engulfing Patterns & Insights From Wall Street Professionals - earlytimes.in
Form 424B5 MAINZ BIOMED N.V. - StreetInsider
Mainz Biomed (NASDAQ:MYNZ) Upgraded by Wall Street Zen to Hold Rating - Defense World
Mainz Biomed (NASDAQ:MYNZ) Stock Price Up 2.7% – Still a Buy? - Defense World
Why retail investors favor Mainz Biomed N.V. stockSwing Trade & Fast Gaining Stock Strategy Reports - Улправда
Why Mainz Biomed N.V. (4TO) stock is a strong buy callJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Why Mainz Biomed N.V. stock remains undervalued2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Улправда
Will Mainz Biomed N.V. stock reach all time highs in 20252025 Year in Review & Weekly Watchlist of Top Performers - Улправда
How Mainz Biomed N.V. stock reacts to inflationary pressuresJuly 2025 Sector Moves & Verified Momentum Watchlists - ulpravda.ru
2 Small-Cap Biotechs That Could Reward Patient Investors - Investing.com
2 Small-Cap Biotechs That Could Reward Patient Investors - sharewise.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Mainz Biomed N.V. stock positioned for long term growthJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser
Mainz Biomed (Nasdaq: MYNZ) targets $150M shelf to advance cancer diagnostics - Stock Titan
Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsWeekly Market Outlook & Stock Portfolio Risk Control - Newser
Can Mainz Biomed N.V. (4TO) stock sustain free cash flow2025 Top Gainers & Fast Moving Stock Trade Plans - Newser
Mainz Biomed N V Azioni (MYNZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):